Skip to Content

QuidelOrtho Corp QDEL

Morningstar Rating
$34.49 +1.28 (3.85%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

QDEL is trading within a range we consider fairly valued.
Price
$33.28
Fair Value
$37.50
Uncertainty
Very High
1-Star Price
$718.43
5-Star Price
$84.93
Economic Moat
Xjmn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if QDEL is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$33.21
Day Range
$33.0034.50
52-Week Range
$29.7588.94
Bid/Ask
$34.48 / $34.53
Market Cap
$2.31 Bil
Volume/Avg
405,089 / 960,617

Key Statistics

Price/Earnings (Normalized)
11.99
Price/Sales
0.78
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
7,100

Comparables

Valuation

Metric
QDEL
TIHE
FLGT
Price/Earnings (Normalized)
11.99
Price/Book Value
0.670.58
Price/Sales
0.782.29
Price/Cash Flow
5.7522.17
Price/Earnings
QDEL
TIHE
FLGT

Financial Strength

Metric
QDEL
TIHE
FLGT
Quick Ratio
0.684.81
Current Ratio
1.555.09
Interest Coverage
−9.30−3,451.87
Quick Ratio
QDEL
TIHE
FLGT

Profitability

Metric
QDEL
TIHE
FLGT
Return on Assets (Normalized)
1.52%−0.46%
Return on Equity (Normalized)
2.68%−0.50%
Return on Invested Capital (Normalized)
3.97%−1.73%
Return on Assets
QDEL
TIHE
FLGT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
JygpcjnvrVnxvb$174.1 Bil
Stryker Corp
SYK
PtzbntyxyFsb$126.2 Bil
Boston Scientific Corp
BSX
YrbzmsqmFbxkfvj$111.1 Bil
Medtronic PLC
MDT
MvpgkggmzFtzqrnq$104.1 Bil
Edwards Lifesciences Corp
EW
ZjrkqhcnzSvqzc$51.7 Bil
DexCom Inc
DXCM
MqsxjtwcsQsdp$43.8 Bil
Koninklijke Philips NV ADR
PHG
QzkfnytzmHxqmpmg$24.7 Bil
Zimmer Biomet Holdings Inc
ZBH
MblhbhnwGdvt$22.9 Bil
Steris PLC
STE
GhdrjdnjCcjkz$22.3 Bil
Align Technology Inc
ALGN
FymmxqtTywxcfl$18.9 Bil

Sponsor Center